Related Experiment Video
Updated: May 19, 2026
11:00
High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
Genetic testing for respiratory disease: are we there yet?
1University of British Columbia, James Hoog Research Centre, St. Paul's Hospital, Vancouver, British Columbia. Peter.Pare@hli.ubc.ca
Canadian Respiratory Journal
|August 15, 2012
Summary
The Human Genome Project aimed for personalized medicine in respiratory disease care. This review assesses progress and questions the value of widespread genetic screening for respiratory conditions.
Area of Science:
- Genomics
- Respiratory Medicine
- Personalized Healthcare
Background:
- The Human Genome Project heralded personalized medicine, tailoring healthcare based on individual genetic information.
- This approach offers potential for predicting and modifying disease risk through lifestyle and preventive strategies.
- Respiratory diseases remain a significant global health burden, necessitating innovative management approaches.
Purpose of the Study:
- To evaluate the progress made in applying personalized medicine principles to respiratory disease.
- To critically assess the potential benefits and drawbacks of implementing generalized population screening for genetic risk factors in respiratory conditions.
- To inform the debate on the future of genetic screening in respiratory healthcare.
Main Methods:
- A review of current literature and research on genetic risk factors for respiratory diseases.
- Analysis of the advancements in genomic technologies and their clinical applicability.
- Discussion of the ethical, social, and practical considerations of population-wide genetic screening.
Main Results:
- Progress in personalized medicine for respiratory diseases has been incremental, with some specific genetic markers identified for certain conditions.
- The translation of genetic discoveries into widespread clinical practice for respiratory diseases remains challenging.
- The utility and cost-effectiveness of generalized population screening for respiratory genetic risk factors are not yet established.
Conclusions:
- While personalized medicine holds promise for respiratory care, widespread genetic screening is not currently recommended due to insufficient evidence and potential challenges.
- Further research is needed to identify robust genetic predictors and develop effective interventions for respiratory diseases.
- A targeted approach, focusing on specific high-risk populations or conditions, may be more appropriate than generalized screening.
Related Concept Videos
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Pulmonary Function Tests
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...